We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ICL

News List

Antibodies against SARS-CoV-2 wane over time, suggesting immunity may be short-lived: GlobalData expresspharma
October 29, 2020
Following new data from Imperial College London (ICL) suggesting that antibody levels against SARS-CoV-2 wane over time; Michael Breen, Director of Infectious Diseases and Ophthalmology at GlobalData offers his view.
CEPI, Imperial College partner for emerging diseases vaccines pharmatimes
December 11, 2018
The Coalition for Epidemic Preparedness Innovations (CEPI) and Imperial College London have announced a partnership to develop a self-amplifying RNA vaccine platform (saRNA), enabling tailored vaccine production against multiple viral pathogens.